226 related articles for article (PubMed ID: 21249144)
41. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
Franzoso G; Bours V; Azarenko V; Park S; Tomita-Yamaguchi M; Kanno T; Brown K; Siebenlist U
EMBO J; 1993 Oct; 12(10):3893-901. PubMed ID: 8404857
[TBL] [Abstract][Full Text] [Related]
42. Bcl3: a regulator of NF-κB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells.
Poveda J; Sanz AB; Carrasco S; Ruiz-Ortega M; Cannata-Ortiz P; Sanchez-Niño MD; Ortiz A
Exp Mol Med; 2017 Jul; 49(7):e352. PubMed ID: 28684863
[TBL] [Abstract][Full Text] [Related]
43. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis.
Budunova IV; Perez P; Vaden VR; Spiegelman VS; Slaga TJ; Jorcano JL
Oncogene; 1999 Dec; 18(52):7423-31. PubMed ID: 10602501
[TBL] [Abstract][Full Text] [Related]
44. Suppression of transcription factor NF-kappaB activity by Bcl-2 protein in NIH3T3 cells: implication of a novel NF-kappaB p50-Bcl-2 complex for the anti-apoptotic function of Bcl-2.
Hour TC; Chen L; Lin JK
Eur J Cell Biol; 2000 Feb; 79(2):121-9. PubMed ID: 10727020
[TBL] [Abstract][Full Text] [Related]
45. NF-kappa B p50 regulates C/EBP alpha expression and inflammatory cytokine-induced neutrophil production.
Wang D; Paz-Priel I; Friedman AD
J Immunol; 2009 May; 182(9):5757-62. PubMed ID: 19380823
[TBL] [Abstract][Full Text] [Related]
46. Involvement of 5'-flanking kappaB-like sites within bcl-x gene in silica-induced Bcl-x expression.
Chen F; Demers LM; Vallyathan V; Lu Y; Castranova V; Shi X
J Biol Chem; 1999 Dec; 274(50):35591-5. PubMed ID: 10585435
[TBL] [Abstract][Full Text] [Related]
47. Heightened TWEAK-NF-κB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury.
Yarar-Fisher C; Bickel CS; Kelly NA; Stec MJ; Windham ST; McLain AB; Oster RA; Bamman MM
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E754-61. PubMed ID: 26931128
[TBL] [Abstract][Full Text] [Related]
48. Identification and characterization of nuclear factor kappaB binding sites in the murine bcl-x promoter.
Glasgow JN; Wood T; Perez-Polo JR
J Neurochem; 2000 Oct; 75(4):1377-89. PubMed ID: 10987817
[TBL] [Abstract][Full Text] [Related]
49. NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells.
Chang PY; Draheim K; Kelliher MA; Miyamoto S
Cancer Res; 2006 Jun; 66(12):6008-13. PubMed ID: 16778171
[TBL] [Abstract][Full Text] [Related]
50. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
[TBL] [Abstract][Full Text] [Related]
51. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade.
Carmody RJ; Ruan Q; Palmer S; Hilliard B; Chen YH
Science; 2007 Aug; 317(5838):675-8. PubMed ID: 17673665
[TBL] [Abstract][Full Text] [Related]
52. NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.
Puvvada SD; Funkhouser WK; Greene K; Deal A; Chu H; Baldwin AS; Tepper JE; O'Neil BH
Oncology; 2010; 78(3-4):181-8. PubMed ID: 20414006
[TBL] [Abstract][Full Text] [Related]
53. Complex regulation of acute and chronic neuroinflammatory responses in mouse models deficient for nuclear factor kappa B p50 subunit.
Rolova T; Puli L; Magga J; Dhungana H; Kanninen K; Wojciehowski S; Salminen A; Tanila H; Koistinaho J; Malm T
Neurobiol Dis; 2014 Apr; 64():16-29. PubMed ID: 24345324
[TBL] [Abstract][Full Text] [Related]
54. BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit.
Li Z; Wang X; Yu RY; Ding BB; Yu JJ; Dai XM; Naganuma A; Stanley ER; Ye BH
J Immunol; 2005 Jan; 174(1):205-14. PubMed ID: 15611242
[TBL] [Abstract][Full Text] [Related]
55. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
56. Deletion of nuclear factor-κB p50 upregulates fatty acid utilization and contributes to an anti-obesity and high-endurance phenotype in mice.
Minegishi Y; Haramizu S; Misawa K; Shimotoyodome A; Hase T; Murase T
Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E523-33. PubMed ID: 26173458
[TBL] [Abstract][Full Text] [Related]
57. Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42.
Turnham DJ; Yang WW; Davies J; Varnava A; Ridley AJ; Conlan RS; Clarkson RWE
Carcinogenesis; 2020 Oct; 41(10):1432-1443. PubMed ID: 31957805
[TBL] [Abstract][Full Text] [Related]
58. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells.
Ammon C; Mondal K; Andreesen R; Krause SW
Biochem Biophys Res Commun; 2000 Feb; 268(1):99-105. PubMed ID: 10652220
[TBL] [Abstract][Full Text] [Related]
59. The regulation of sequence specific NF-κB DNA binding and transcription by IKKβ phosphorylation of NF-κB p50 at serine 80.
Smith EL; Somma D; Kerrigan D; McIntyre Z; Cole JJ; Liang KL; Kiely PA; Keeshan K; Carmody RJ
Nucleic Acids Res; 2019 Dec; 47(21):11151-11163. PubMed ID: 31598684
[TBL] [Abstract][Full Text] [Related]
60. Oxidative, multistep activation of the noncanonical NF-kappaB pathway via disulfide Bcl-3/p50 complex.
Cristofanon S; Morceau F; Scovassi AI; Dicato M; Ghibelli L; Diederich M
FASEB J; 2009 Jan; 23(1):45-57. PubMed ID: 18796561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
